Clinical evaluation of natalizumab for formulary consideration

Author： Bivins Ashley Hou Karolyn Ayesu Nana Ellsworth Brian Montenegro Susan Tu Xiao Boyle Cynthia Dowling Thomas Shaya Fadia T

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.10, Iss.8, 2010-08, pp. : 1279-1287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Flow Cytometric Parameters for Characterizing Platelet Activation by Measuring P-Selectin (CD62) Expression: Theoretical Consideration and Evaluation in Thrombin-Treated Platelet Populations

By Leytin V. Mody M. Semple J.W. Garvey B. Freedman J.

Biochemical and Biophysical Research Communications, Vol. 269, Iss. 1, 2000-03 ,pp. : 85-90

Elsevier

Access to resources Recommend Favorite

Synthesis and Biochemical Evaluation of Novel Inhibitors of Aromatase (AR) Using an Enhanced Representation of the Active Site of AR Derived from the Consideration of the Reaction Mechanism

By Ahmed S. Amanuel Y.

Biochemical and Biophysical Research Communications, Vol. 267, Iss. 1, 2000-01 ,pp. : 356-361

Elsevier

Access to resources Recommend Favorite

Clinical evaluation of Deferasirox for removal of cadmium ions in rat

By Saljooghi Amir

BioMetals, Vol. 23, Iss. 4, 2010-08 ,pp. : 707-712

Springer Publishing Company

Access to resources Recommend Favorite

L-methionine as immune supportive supplement: a clinical evaluation

By Van Brummelen R. du Toit D.

Amino Acids, Vol. 33, Iss. 1, 2007-07 ,pp. : 157-163

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of clinical colon carcinoma using activity-based proteomic profiling

By Zhang Melissa

Clinical Proteomics, Vol. 1, Iss. 3-4, 2004-09 ,pp. : 301-311

Humana Press, Inc

Access to resources Recommend Favorite